Skip to Content

V268 (Av-Phos 250 Neutral sodium phosphate (dibasic) 852 mg, potassium phosphate (monobasic) 155 mg and sodium phosphate (monobasic) 130 mg)

Generic Name: potassium phosphate/sodium phosphate

Pill with imprint V268 is White, Capsule-shape and has been identified as Av-Phos 250 Neutral sodium phosphate (dibasic) 852 mg, potassium phosphate (monobasic) 155 mg and sodium phosphate (monobasic) 130 mg. It is supplied by AvKare Inc.

Av-Phos 250 Neutral is used in the treatment of hypophosphatemia; urinary acidification and belongs to the drug class minerals and electrolytes. Risk cannot be ruled out during pregnancy. Av-Phos 250 Neutral sodium phosphate (dibasic) 852 mg, potassium phosphate (monobasic) 155 mg and sodium phosphate (monobasic) 130 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for V268

Av-phos 250 neutral sodium phosphate (dibasic) 852 mg, potassium phosphate (monobasic) 155 mg and sodium phosphate (monobasic) 130 mg V268

Av-Phos 250 Neutral

Generic Name
potassium phosphate/sodium phosphate
Imprint
V268
Strength
sodium phosphate (dibasic) 852 mg, potassium phosphate (monobasic) 155 mg and sodium phosphate (monobasic) 130 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Minerals and electrolytes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
AvKare Inc
National Drug Code (NDC)
42291-0152
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, magnesium stearate, silicon dioxide, stearic acid, polydextrose, polyethylene glycol 4000, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "V268"

More about Av-Phos 250 Neutral (potassium phosphate / sodium phosphate)

Consumer resources

Other brands: PHOS-NaK, Phospha 250 Neutral, K-Phos Neutral, K-Phos M.F., K-Phos No. 2

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.